DermTech Inc. Common Stock (DMTK)
About The Company
DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services.
IPO Year | Sector | Industry |
---|---|---|
2017 | Health Care | Managed Health Care |
DermTech Inc. (DMTK) Latest News
Company Contact & Address (DMTK)
Corporate Headquarters | Phone | Website |
---|---|---|
11099 N. TORREY PINES ROAD SUITE 100, LA JOLLA, California, 92037, United States |
+1 858 450-4222 | Official DMTK Website |
DMTK Key Executives
Ownership and management information.
Key Data Points*
Exchange | Not Available | Market Cap | Not Available |
---|---|---|---|
Sector | Health Care | P/E Ratio | Not Available |
Industry | Managed Health Care | Forward P/E 1 Yr. | Not Available |
1 Year Target | Not Available | Earnings Per Share (EPS) | Not Available |
Today’s High/Low | Not Available | Annualized Dividend | Not Available |
Share Volume | Not Available | Ex Dividend Date | Not Available |
Average Volume | Not Available | Dividend Pay Date | Not Available |
Previous Close | Not Available | Current Yield | Not Available |
52 Week High/Low | Not Available | Beta | Not Available |
* Information and data may delayed
Officers & Directors @ DMTK
Jobs & Employment at DermTech Inc.
LinkedIn Company Page | https://www.linkedin.com/company/dermtech |
---|---|
Official Career & Employment Page | Jobs & Employment at DermTech Inc. (DMTK) |
Related & Similar Stock Symbols
![]() PMT^BPennyMac Mortgage Investment Trust 8.00% Series B Fixed-to-Floating …
|
![]() OGNOrganon & Co. Common Stock
|
![]() UPTDUTradeUP Acquisition Corp. Unit
|